Pacira BioSciences Inc (NAS:PCRX)
$ 16.81 -0.7 (-4%) Market Cap: 776.17 Mil Enterprise Value: 998.18 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 72/100

Pacira Biosciences Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2020 / 01:00PM GMT
Release Date Price: $33.11 (-5.91%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. Continuing our health care conference virtually for day 3, we have with us today, Pacira Pharmaceuticals to -- for the 9 a.m. session. And from the management team side, we have with us Dave Stack, Chairman and CEO of Pacira; Ron Ellis, Senior Vice President, Corporate Strategy and Business Development; and Susan Mesco, Head of Investor Relations. Dave, Ron and Susan, good morning, and thank you for joining us.

David M. Stack
Pacira BioSciences, Inc. - Chairman & CEO

Good morning, Balaji. And Charlie Reinhart, our CFO, is also with us here.

Charles A. Reinhart
Pacira BioSciences, Inc. - CFO

Good morning.

Questions & Answers

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

So maybe a good point to start, Dave and Charlie, is the resounding guidance you gave

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot